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Abstract
Introduction. Pediatric malaria, even in countries considered as free as Italy, is an im-
portant problem of public health because children have a high variability of the clinical 
picture. The objective of this brief note is to determine the incidence of pediatric malaria 
in the Piedmont Region during the period 1989-2015. 
Materials and methods. All cases of pediatric malaria notified were considered thanks 
to the regional information flow over the period 1989-2015. Cases of congenital malaria, 
unconfirmed malaria cases, and aged 14 and older were excluded of the study. 
Results. In Piedmont in the period 1989-2015, pediatric malaria accounts for 8.8% of 
the total (172/1946 cases). 74% of patients are of foreign nationality, to which must be 
added the 14% represented by those born in Italy from foreign parents, while it is 100% 
the fraction of patients who have made a trip to the abroad. The notification of cases is 
greater in the autumn months. Only 7.6% of the sample carried out a complete chemo-
prophylaxis. In 79% of cases, the primary care physician advised chemoprophylaxis on 
trips to endemic areas.
Conclusions. At present, lacking an effective vaccine, the prevention and implementa-
tion of standard precautions such as chemoprophylaxis, represent the safest strategy to 
put into practice to eradicate the disease especially for the groups at greater risk as visit-
ing friends and relatives. 
INTRODUCTION
Malaria is a disease caused by Plasmodium proto-
zoans (Plasmodium falciparum, Plasmodium vivax, Plas-
modium ovale, Plasmodium malariae and Plasmodium 
Knowlesi) transmitted to humans by the bite of some 
species of female mosquito of the genus Anopheles. 
Plasmodium falciparum is the most prevalent malaria 
parasite in sub-Saharan Africa (100%), the Western Pa-
cific (72%), Eastern Mediterranean (69%) and South 
East Asia (63%), while Plasmodium vivax is the domi-
nant malaria species in the Americas (74%) [1]. 
The symptoms, depending on the plasmodium spe-
cies, appears 7-15 or more days after the bite of the 
infected mosquito. They are consistent in fever, often 
very high, headache, vomiting, diarrhea, sweating and 
shaking chills, all symptoms, at least existing, common 
to any flu syndrome or other infections.
Malaria cases are classified according to the termi-
nology adopted by the WHO in 1963, as follows: a 
case of malaria is considered to be imported when the 
infection was contracted in a country other than that 
in which it is diagnosed; autochthonous when it is lo-
cally contracted. Among the autochthonous cases are 
defined induced, those caused by transfusions or other 
form of parenteral inoculation (transplants, nosocomial 
infections, etc.); introduced the secondary cases locally 
contracted after the bite of an indigenous mosquito in-
fected on an importation case (bearer of gametocytes) 
or contracted with the bite of an infected mosquito ac-
cidentally imported (malaria from luggage, from the air-
port). A cryptic case is an isolated case of malaria that 
after an adequate epidemiological investigation cannot 
be classified in any of the categories described above. In 
the period 2013-2017 in Italy there were 3805 cases of 
malarial cases, of which 12 cases were autochthonous, 
4 induced and 8 cryptic, with a peak of 7 cases occurred 
in summer 2017 that created a great concern for public 
health [1].
WHO’s World Malaria Report has estimated that in 
2017 the number of total cases was around 219 million, 
with about 435 000 deaths [2]. Although it represents 
one of the most widespread diseases in the world, 92% 
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of cases and 93% of deaths occurred on the African 
continent. 
However, in the latest years the spread of malaria 
has considerably reduced thanks to increasing fight and 
control plans and since 2016 WHO announced that the 
autochthonous transmission of malaria in European 
states was eradicated [3].
Yet, because of global migrator fluxes’ increase and 
growing number of international travelers, in non- en-
demic countries malaria continues to be the most im-
portant import disease [4].
Worldwide, imported malaria is defined as a malaria 
infection acquired in an endemic area of malaria but 
diagnosed in no endemic country. Italy is included by 
WHO among malaria-free countries since 1970 but the 
attention remains very high because cases imported 
into areas that are no longer endemic may represent 
infection’s sources due to the presence of competent 
vectors on the territory, allowing the reactivation of a 
local transmission, as recently happened in Greece [5].
In areas of high malaria transmission, children under 
the age of 5 are particularly vulnerable to infection and 
develop the disease in severe form. In 2017, 61% of 
deaths (266 000) affected this age group [2]. Pediatric 
malaria is an important public health problem because 
clinical picture is highly variable for children, and often 
not easily attributable to the disease. Children develop 
more severe disease’s forms especially before the age of 
5, with a greater probability of death than adults [6].
The objective is to determine the incidence of pedi-
atric malaria in the region of Piedmont in the period 
1989-2015. Secondary objectives are the determination 
of the incidence of malaria cases among European and 
Non-European citizens, the determination of the per-
centage of malaria cases despite chemoprophylaxis and 
the determination of the increase in notifications post 
holidays periods.
MATERIALS AND METHODS
The study evaluated all cases of pediatric malaria 
notified and recovered through in Piedmont thanks to 
regional information flow in the period 1989-2015. The 
composition of the study sample included all confirmed 
cases of malaria in the age group up to 14 years, re-
gardless of nationality and sex. The exclusion criteria 
applied were: unconfirmed cases of malaria, age over 14 
years, congenital malaria cases. The analysis provided 
a quantitative stratification for some characteristics: 
nationality, notification month of malaria cases, travel 
destination and fulfillment prophylaxis. The notification 
forms analyzed did not allow us to describe the clinical 
course and the severity of the individual case. In fact it 
was not possible to consult the medical records. Fur-
thermore, another aspect that could not be investigated 
was the possible diagnostic delay.
CASE DEFINITION
The criteria adopted for the identification of the case 
are those provided by the Italian Ministry of Health [7]: 
a case of malaria is defined as a symptomatic, paucisin-
tomatic or asymptomatic individual in which there is the 
presence of malarial parasites with diagnostic methods 
that have clinics, epidemiological or laboratory criteria. 
The classification offers the possibility of having a prob-
able case, in which the clinical and epidemiological cri-
teria are met, and a confirmed case, in which the labora-
tory criterion (microscopic confirmation) is also satisfied. 
Only confirmed cases were considered in this study.
RESULTS
Among 1946 malaria cases notified in Piedmont in 
the period 1989-2015, pediatric malaria represents 8.8 
% of total (n. 172), the case-fatality rate is 0.58 %, due 
to a single case of death in the study sample. The most 
represented species of Plasmodium protozoans was the 
Plasmodium falciparum (150 cases) Plasmodium vivax 
(3 cases), Plasmodium ovale (8 cases); there were also 
3 cases of mixed forms and 9 cases in which the agent 
is not specified. The stratification of the sample by citi-
zenship has shown that the largest share of patients is of 
foreign nationality. They represent 74% (n. 127) of the 
sample, while 12% (n. 21) of the sample is represented 
by Italian citizens and 14% (n. 24) by children born in 
Italy from foreign parents. The 100% of the sample is 
the share of patient who travelled abroad. The country 
of destination was North e West Africa for over 95% of 
cases, around 60% of the notifications, in fact, come 
from people who have visited the Ivory Coast and Nige-
ria. There were several reasons behind those travels, but 
in the most cases it was for returning to the country of 
origin, Table 1 shows the destination and the reason for 
the trip and the use of chemoprophylaxis.
August, September and October and partly even No-
vember and January are the months in which the larg-
est number of diagnosis occurred, as a consequence 
of people returning from journeys taken during school 
summer and winter breaks (Figure 1). 
The notification forms analyzed starting from 2003 
are enriched with some information: type of trip, type 
and method of chemoprophylaxis and operator who 
recommended chemoprophylaxis. Considering that the 
data is partial, related to 131 cases, the data we present 
are not to be considered general.
Only 7.6% of the sample received a complete che-
moprophylaxis. Moreover, it should be considered that 
26% of malaria cases are not preventable by a prophy-
laxis, as they concern that share of children reaching 
Italy via immigration. Mefloquine was the most used 
molecule in either complete or partial chemoprophylax-
is. It was the family doctor (general practitioner/family 
pediatrician) that in most cases (79%) recommended a 
chemoprophylaxis before a trip to endemic areas. 
DISCUSSION
According to Surveillance Atlas of Infectious Diseas-
es data of the European Center for Disease Prevention 
and Control (ECDC) for 2017, 8401 cases of malaria 
were reported in the EU/EEA, 8393 (99.9%) of which 
were confirmed and almost all cases of malaria reported 
by EU countries for 2017 have been imported [8].
France reported the highest number of cases, fol-
lowed by the United Kingdom, Germany and Italy.
All countries that report the greatest number of 
cases have historical, economic, linguistic and cultural 
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links with endemic areas, particularly in Africa and the 
Americas. Most cases of malaria imported into France 
and the United Kingdom are linked to travel routes 
from West Africa [4]. Italy was the fourth country in 
terms of number of notifications, after France, United 
Kingdom and Germany, with 830 reported malaria cas-
es, of which about 12% of pediatric malaria cases.
Although the Member States of the European Union 
have been free from malaria since 1975, the presence of 
the vector of the genus Anopheles is frequently docu-
mented [9]. Italy in particular seems to remain a risk 
zone due to the vector competence of some species of 
Anophele (Anopheles superpictus, A. sacharovi and A. 
labranchiae) and the high malarious degree [10].
Over the last 10 years occasional cases of indigenous 
malaria were reported in several European countries. 
In almost all cases it was “airport malaria” [9]. How-
ever, malaria is more frequently introduced in Europe 
through importation, which has multiple variable: 
increased international travels, especially in tropical 
and subtropical areas, more immigrants from coun-
tries where malaria is endemic, and the role of visiting 
friends and relatives (VFRs).
VFRs are individuals from low-income countries who 
having settled in high-income countries periodically go 
back to their native country to visit relatives and friends. 
This population of immigrants alone counts for 50% of 
international travelers [10]. They represent a group of 
travelers particularly at risk with regard to travel-related 
diseases, more than other kind of travelers (tourists, 
business-travelers) [11].
VFRs visit rural areas more frequently and stay there 
longer than those who travel in risk area for tourism 
or business, and probably in healthier conditions.  Fur-
thermore, with regard to malaria, VFRs may have a low-
er perception of risk, believing that they have a perma-
nent immunity to infection, acquiring with birth in the 
endemic country, without considering the potential for 
a relapse of the infection. This leads to a lower employ-
ment of available preventive measures: repellents, mos-
quito nets, air conditioning and chemoprophylaxis [12], 
and also for their children. Even the subpopulations 
belonging to the group of traveler VFRs, like pregnant 
women and pediatric individuals, seems to be slightly 
sensitive about preventive measures [13].
VFRs may represent up to 70% of imported malaria 
cases in developed countries [11]. Data analyzed in this 
study also show how the greater incidence of pediatric 
malaria occurs during periods corresponding to school 
summer holidays (August, September and October) 
and Christmas festivities (December and January), dur-
ing which VFRs often go back to their native country 
(Figure 1).
CONCLUSION
Imported malaria represents one of the most diag-
nosed diseases in developed countries, but at the same 
time one of the most preventable if standard precau-
Table 1
Reason and destination of travel and use of malaria chemoprophylaxis*
Destination Reasons Type of prophylaxis 
Benin 
Burkina Faso 
Cameroon 
Congo
Ivory Coast
Ghana
Equatorial Guinea
India
Kenya
Liberia
Madagascar
Mali
Nigeria
Not reported 
Senegal
Togo
3
16
10
8
27
9
3
3
2
1
2
4
73
1
9
1
Immigration
Parental work 
Residence
Return of origin country
Tourism
Other
Does not know
26 (15%)
2 (1.2%)
3 (1.7%)
102 (59.3%)
20 (11.6%)
2 (1.2%)
17 (9.9%)
Atovaquone/Proguanil 
Mefloquine
Quinine
None 
Not remeber
2 
33
1
65
30 
Subdivision by citizenship
Percentage of sick people who have carried out 
chemoprophylaxis during travel*
Italian
Foreign
Born in Italy from foreign parents
21 (12%)
127 (74%)
24 (14%)Complete chemoprophylaxis
Missed doses
Not executed
Interrupted
Late
Not remember
Partial chemoprophylaxis
10 (7.6%)
6 (4.6%)
65 (49.6%)
12 (9.1%)
3 (2.2%)
30 (22.9%)
5  (3.8%)
Clinicians who recommended 
chemoprophylaxis 
Travel medicine surgery
Family Doctor
Does not know
26 (20%)
103 (79%)
2 (1.5%)
*Reference period 2003-2015 131 cases.
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Figure 1
Diagnosis of malaria by month, cumulative 1989-2015 (n. 172 
pediatric cases in the Piedmont Region, Italy).
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tions were always adopted. VFRs are one of the group 
most at risk of contracting malaria and importing it in 
developed countries. This multiethnic and diverse cat-
egory should represent the main target of awareness 
policies of the actors in charge of the purpose. Howev-
er, there seems to be many implementation difficulties: 
VFRs often consider chemoprophylaxis as an almost ex-
aggerated precaution for a disease that is been known 
since childhood [14]; furthermore, socio-economic dif-
ficulties, lack of knowledge of prevention tools and lack 
of knowledge of the correct and timely use of health 
and social services.
Prevention and awareness-raising strategy should thus 
be extensive and systematic, especially for VFRs individ-
uals who are integrated into society in developed coun-
tries. Many actors shall be involved: general practitioner, 
family pediatrician, pharmacists, primary school teach-
ers. Furthermore, an extensive information might be of-
fered also in workplaces and places of entertainment. 
In Europe, malaria chemoprophylaxis is recom-
mended only for travelers in malaria endemic countries, 
which are classified into different groups to determine 
the most effective drug regimen [15]. The choice of 
prophylactic drugs and prevention measures also de-
pend mainly on the local epidemiology of malaria, on 
the duration of potential exposure to vectors, on the 
model of resistance to parasites, on the level and sea-
sonality of transmission, on tolerance to prophylactic 
drugs, from age and pregnancy.
Currently, in the absence of an effective vaccine, 
prevention and implementation of standard precau-
tion represent the safest strategy to put into practice to 
eradicate malaria.
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